South Wales, April 10 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "LENLOVIQ" on March 26. The details about the trademark application no. UK00004362822 published in the journal no. 2026/015 (April 10).
With Aneta Stawska as representative, Gilead Sciences Ireland UC filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention of HIV infection; Pharmaceutical preparations for the treatment and prevention of HIV infection.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004362822
Disclaimer: Curated by HT Syndication.
